{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:36:30Z","timestamp":1789385790881,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":950,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","award":["GB"],"award-info":[{"award-number":["GB"]}],"id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA150272P9"],"award-info":[{"award-number":["CA150272P9"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01-HL116329"],"award-info":[{"award-number":["1R01-HL116329"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P30 CA196521-SF"],"award-info":[{"award-number":["P30 CA196521-SF"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 17608"],"award-info":[{"award-number":["AIRC 17608"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01-CA108671"],"award-info":[{"award-number":["P01-CA108671"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK56621"],"award-info":[{"award-number":["R01-DK56621"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.exphem.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:31:21Z","timestamp":1572665481000},"page":"16-25.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia"],"prefix":"10.1016","volume":"79","author":[{"given":"Genta","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadassa","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Varricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2019.10.001_bib0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.1208","article-title":"MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis","volume":"198","author":"Yoshida","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0002","doi-asserted-by":"crossref","first-page":"L1180","DOI":"10.1152\/ajplung.2001.281.5.L1180","article-title":"Induction of c-jun and TGF-beta 1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis","volume":"281","author":"Chung","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0003","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1083\/jcb.201109045","article-title":"JunB contributes to Id2 repression and the epithelial\u2013mesenchymal transition in response to transforming growth factor-\u03b2","volume":"196","author":"Gervasi","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0004","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1073\/pnas.1621375114","article-title":"Unifying mechanism for different fibrotic diseases","volume":"114","author":"Wernig","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2019.10.001_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.10.001_bib0006","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.leu.2404914","article-title":"Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A consensus statement from the International Working Group for Myelofibrosis Research and Treatment","volume":"22","author":"Barosi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2019.10.001_bib0007","doi-asserted-by":"crossref","first-page":"700","DOI":"10.12688\/f1000research.8081.1","article-title":"Recent advances in understanding myelofibrosis and essential thrombocythemia","volume":"5","author":"Vainchenker","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.exphem.2019.10.001_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exphem.2018.12.004","article-title":"Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: The 159th biomedical version of \u201cit takes two to tango.\u201d","volume":"70","author":"Zhan","year":"2019","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbamcr.2007.08.004","article-title":"Disruption of the latent transforming growth factor-\u03b2 binding protein-1 gene causes alteration in facial structure and influences TGF-\u03b2 bioavailability","volume":"1783","author":"Drews","year":"2008","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.exphem.2019.10.001_bib0010","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2015-309655","article-title":"A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.exphem.2019.10.001_bib0011","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1096\/fj.201600373R","article-title":"Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis","volume":"30","author":"Peng","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2019.10.001_bib0012","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.20668","article-title":"Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin","volume":"113","author":"Prusty","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2019.10.001_bib0013","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/jvi.71.1.362-370.1997","article-title":"Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription","volume":"71","author":"R\u00f6sl","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0014","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/j.1460-2075.1996.tb00546.x","article-title":"The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors","volume":"15","author":"Antinore","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2019.10.001_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcmd.2014.12.005","article-title":"Activation of non-canonical TGF-beta1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis","volume":"54","author":"Ciaffoni","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.exphem.2019.10.001_bib0016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms\u2019 tumor gene 1 (WT1)","volume":"25","author":"Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2019.10.001_bib0018","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-60327-530-9_13","article-title":"Molecular characterization of inflammation-Induced JNK\/c-Jun signaling pathway in connection with tumorigenesis","volume":"512","author":"Kaminska","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0019","first-page":"34","article-title":"A novel interaction between megakaryocytes and activated fibrocytes increases TGF-\u03b2 bioavailability in the Gata1(low) mouse model of myelofibrosis","volume":"5","author":"Zingariello","year":"2015","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.exphem.2019.10.001_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0167-4781(00)00308-0","article-title":"Isolation and characterization of cDNAs for the protein kinase HIPK2","volume":"1518","author":"Wang","year":"2001","journal-title":"Biochim Biophys Acta Gene Struct Expr"},{"key":"10.1016\/j.exphem.2019.10.001_bib0021","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.febslet.2005.04.053","article-title":"Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation","volume":"579","author":"Ki","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2019.10.001_bib0022","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nm.2685","article-title":"A systems approach identifies HIPK2 as a key regulator of kidney fibrosis","volume":"18","author":"Jin","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2019.10.001_bib0023","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00109-013-1042-0","article-title":"Posttranslational modifications regulate HIPK2, a driver of proliferative diseases","volume":"91","author":"Saul","year":"2013","journal-title":"J Mol Med"},{"key":"10.1016\/j.exphem.2019.10.001_bib0024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.24129","article-title":"Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis","volume":"228","author":"Ricci","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jmcb\/mjs053","article-title":"HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop","volume":"5","author":"Saul","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0026","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1535370213489441","article-title":"Molecular basis of organ fibrosis: Potential therapeutic approaches","volume":"238","author":"Ghosh","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.exphem.2019.10.001_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGF\u03b2 signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.10.001_bib0028","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-439661","article-title":"Characterization of the TGF-b1 signaling abnormalities in the Gata1low mouse model of myelofibrosis","volume":"121","author":"Zingariello","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.10.001_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.10.001_bib0030","doi-asserted-by":"crossref","first-page":"15231","DOI":"10.1073\/pnas.0406771101","article-title":"Transforming growth factor-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation","volume":"101","author":"Scandura","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2019.10.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2016.08.007","article-title":"Preclinical rationale for TGF-\u03b2 inhibition as a therapeutic target for the treatment of myelofibrosis","volume":"44","author":"Ceglia","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0032","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-08-038901","article-title":"Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.10.001_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0939-7","article-title":"Single-cell profiling of human megakaryocyte\u2013erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways","author":"Psaila","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2019.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2015-07-607952","article-title":"Genomic landscape of megakaryopoiesis and platelet function defects","volume":"127","author":"Bianchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.10.001_bib0036","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2019.10.001_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20187784","article-title":"CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis","volume":"52","author":"Nonino","year":"2019","journal-title":"Braz J Med Biol Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X19310720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X19310720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:12:19Z","timestamp":1777547539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X19310720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":37,"alternative-id":["S0301472X19310720"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2019.10.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}